GEO Accession viewer

GSE42044	DNA methylation changes are a late event in Acute Promyelocytic Leukemia and coincide with loss of transcription factor binding (sequencing)
GSE42119	DNA methylation changes are a late event in Acute Promyelocytic Leukemia and coincide with loss of transcription factor binding
GSE43119	The enhancer and promoter landscape of human regulatory and conventional T cell subpopulations
GSE44390	DNA Methyltransferase inhibition reverses epigenetically embedded phenotypes in lung cancer preferentially affecting Polycomb target genes
GSE47188	Transcriptome-based network analysis reveals a spectrum model of human macrophage activation [ChIP-Seq]
GSE47189	Transcriptome-based network analysis reveals a spectrum model of human macrophage activation
GSE47590	5-hydroxymethylcytosine marks promoters in colon that resist hypermethylation in cancer [seq]
GSE47592	5-hydroxymethylcytosine marks promoters in colon that resist hypermethylation in cancer
GSE50692	Uracil DNA glycosylase (UNG) loss enhances DNA double strand break formation in human cancer cells exposed to pemetrexed
GSE51307	Transcriptome-based network analysis reveals a spectrum model of human macrophage activation [miRNA-seq]
GSE52140	Examination of genome-wide methylation changes in lung cancer cell lines A549 (A) and HTB56 (H) [RRBS-Seq experiments]
GSE53172	TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway
GSE55007	Cooperativity and Equilibrium with FOXA1 Define Androgen Receptor Transcriptional Program
GSE59718	Genome-wide hydroxymethylcytosine pattern changes in response to oxidative stress
GSE60424	Next generation sequencing of human immune cell subsets across diseases
GSE61268	HOTAIR or shHOTAIR lentiviral infected prostate cancer cells [ChIP-Seq]
GSE61270	HOTAIR or shHOTAIR lentiviral infected prostate cancer cells
GSE66593	Epigenomic landscapes of human inflammation associated macrophages [RNA-seq]
GSE66595	Epigenomic landscapes of human inflammation associated macrophages
GSE67110	p53 in colorectal cancer cells
GSE67181	Genome-wide miRNA-expression analysis after p53 activation in colorectal cancer cells
GSE69043	Pioneer factor FOXA1 defines GATA2- and AR-mediated transcriptional program in prostate cancer [ChIP-Seq]
GSE69045	Pioneer factor FOXA1 defines GATA2- and AR-mediated transcriptional program in prostate cancer
GSE71276	LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer [ChIP-Seq]
GSE71298	LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer
GSE72634	C/EBPalpha regulated microRNA expression profiling in inducible K562-C/EBPalpha-ER cells
GSE73065	High-throughput single-base resolution mapping of 2’-O-Methylated residues
GSE73363	FOXA1 potentiates lineage-specific enhancer activation through modulating TET1 expression and function
GSE74355	The Common Stress Responsive Transcription Factor ATF3 Binds Active Enhancers and Bookmarks Genomic Sites for Transcriptional Regulation [ChIP-seq]
GSE74363	The Common Stress Responsive Transcription Factor ATF3 Binds Active Enhancers and Bookmarks Genomic Sites for Transcriptional Regulation
GSE77737	Hotspots of aberrant enhancer activity punctuate the colorectal cancer epigenome
GSE79357	Polycomb-mediated deactivation of AR-feedback loop leads to castration-resistant prostate cancer [ChIP-seq]
GSE79358	Polycomb-mediated deactivation of AR-feedback loop leads to castration-resistant prostate cancer
GSE79477	Interaction between cyclooxygenase-2 and caspase-3 abolishes the cleavage of RNA-binding protein HuR and promotes drug resistance in oral squamous cell carcinoma
GSE80274	Identification of extracellular miRNA in archived serum samples by next-generation sequencing from RNA extracted using multiple methods
GSE80523	Expression profile of small nucleolar RNA (snoRNA) in acute myeloid leukemia.
GSE80581	Identification of Amino Enhancer of Split (AES) and DDX21 binding snoRNAs by RIP-Seq.
GSE80602	AML1-ETO induces leukemia via C/D box snoRNA/RNPs.
GSE81859	CD95/Fas increases stemness in cancer cells by inducing a STAT1 dependent Type I interferon response [ChIP-seq]
GSE81860	CD95/Fas increases stemness in cancer cells by inducing a STAT1 dependent Type I interferon response
GSE83115	Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq
GSE83155	Epigenetic regulation of the transcriptional program in memory and terminally differentiated CD8+ T cells [HCAFIS_03_ChIPseq]
GSE83159	Epigenetic regulation of the transcriptional program in memory and terminally differentiated CD8+ T cells
GSE84167	Oxygen responsive lncRNAs in MCF-7 breast cancer cells
GSE85531	Partially exhausted CD8+ T cells are associated with clinically beneficial response to Teplizumab in new onset type I diabetes (whole blood RNA-seq)
GSE85573	Partially exhausted CD8+ T cells are associated with clinically beneficial response to Teplizumab in new onset type I diabetes
GSE93133	The novel lysine specific methyltransferase METTL21B affects mRNA translation through inducible and dynamic methylation of Lys-165 in human eukaryotic elongation factor 1 alpha (eEF1A)
GSE93549	Identification of miR-143 mRNA-targets by AGO-RIP in the myeloid cell line K562
GSE93550	Next Generation Sequencing of miRNome of G-CSF treated huCD34+ HSPCs
GSE94126	Next Generation Sequencing of Gene expression changes in U2OS osteosarcoma cells with PML silencing
GSE95670	Multi-omics analysis of mutant and wild-type β-catenin networks
GSE95721	Expression profile of small nucleolar RNA (snoRNA) in human acute myeloid leukemia with different leukemia stem cell frequency
GSE96562	Single cell RNA-seq reveals expansion of IGRP-reactive CD4+ T cells in recent onset type I diabetes (single-cell RNA-seq of T-cell clone)
GSE96563	Single cell RNA-seq reveals expansion of IGRP-reactive CD4+ T cells in recent onset type I diabetes (bulk RNA-seq of T-cell clone)
GSE96569	Single cell RNA-seq reveals expansion of IGRP-reactive CD4+ T cells in recent onset type I diabetes
GSE97140	Methylation of human eukaryotic elongation factor alpha (eEF1A) by a member of a novel protein lysine methyltransferase family modulates mRNA translation
GSE99820	Effects of WCE herbal extract on hormone-refractory PC-3 tumors
GSE99857	22Rv1 in vivo progression model
GSE101444	Genome-wide hydroxymethylcytosine pattern changes in basal-like breast cancer patients
GSE101445	Genome-wide methylation and hydroxymethylcytosine pattern changes in basal-like breast cancer patients
GSE102360	Selective expression of the transcription elongation factor Eleven Nineteen Lysine-rich Leukemia 3 (ELL3) in actiavted B lymphocytes drives rapid B cell proliferation
GSE104033	The dual methyltransferase METTL13 targets N-terminus and Lys55 of eEF1A and regulates codon-specific translation rates
GSE105052	Small RNA-seq analysis of circulating miRNAs to identify phenotypic variability in Friedreich's ataxia patients
GSE105811	Small RNA Sequencing of Sporadic Amyotrophic Lateral Sclerosis Cerebrospinal Fluid Reveals Differentially Expressed miRNAs Related to Neural and Glial Activity
GSE107780	Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [ChIP-seq]
GSE107782	Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator
GSE108144	TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression [ChIP-seq]
GSE108146	TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression
GSE109298	Enzymatic or in vivo installation of propargyl groups in combination with click chemistry enables enrichment and detection of methyltransferase target sites in RNA
GSE109422	IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors [small RNA]
GSE109604	IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors [mRNA]
GSE109605	IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors
GSE110993	RNA-seq identifies circulating miR-125a-5p, miR-125b-5p and miR-143-3p as potential biomarkers for acute ischemic stroke
GSE114591	A systems biology approach identifies ANP32E and other biomarkers of glucocorticoid refractoriness in ulcerative colitis [miRNA-Seq]
GSE114603	A systems biology approach identifies ANP32E and other biomarkers of glucocorticoid refractoriness in ulcerative colitis
GSE120685	The Role of the RNA-binding protein HuR in MPNST growth and metastasis [RNA-seq]
GSE120687	The Role of the RNA-binding protein HuR in MPNST growth and metastasis
GSE124400	Cell type-specific immune phenotypes predict loss of insulin secretion in new-onset type 1 diabetes
GSE126698	IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis [RNA-Seq]
GSE126729	IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis
GSE128883	Altered chromatin remodeling by FOXA1 mutations promotes androgen independence and prostate cancer aggressiveness [ChIP-seq]
GSE128884	Altered chromatin remodeling by FOXA1 mutations promotes androgen independence and prostate cancer aggressiveness
GSE132361	miRNA expression profiles of macrophages (cell line: RAW264.7) and endothelial cells (cell line: TIME)
GSE133831	Whole transcriptome analysis of human kidney cells after exposure to Ochratoxin A
GSE134475	Hotspot mutations induce metabolic reprogramming and vulnerability to serine deprivation
GSE135390	RNA-seq of human CD4+ T cell subsets
GSE135411	Gene expression analysis in HLHS iPSCs, iPSC-derived cardiac progenitors and cardiomyocytes
GSE138533	Analysis of PDCD4 knockdown effects by high throughput sequencing of a human epithelial cell line
GSE149090	Transcriptomic profiling of human effector and regulatory T cell subsets identifies predictive population signatures
GSE150722	Insulin-like growth factor 2 mRNA-binding protein 3 modulates aggressiveness of Ewing sarcoma by regulating the CD164-CXCR4 axis
GSE151419	Identification of RCC subtype-specific microRNAs – meta-analysis of high-throughput RCC tumor microRNA expression data [RNA-Seq]
GSE151423	Identification of RCC subtype-specific microRNAs – meta-analysis of high-throughput RCC tumor microRNA expression data [miRNA-Seq]
GSE151428	Identification of RCC subtype-specific microRNAs – meta-analysis of high-throughput RCC tumor microRNA expression data
GSE153122	Characterization of Peripheral Blood Mononuclear Cells Gene Expression Profiles of Pediatric Staphylococcus aureus Persistent and Non-Carriers
GSE153583	HOXB13 inhibits lipid metabolism through HDAC3-mediated epigenetic reprogramming [ChIP-Seq]
GSE153586	HOXB13 inhibits lipid metabolism through HDAC3-mediated epigenetic reprogramming
GSE155945	The microRNA landscape of MYCN-amplified neuroblastoma
GSE156598	Transposon mutagenesis screen identifies MHC class II transactivator (CIITA) as an inducer of cellular resistance to Ebola virus and SARS Coronavirus
GSE160928	NOP10 predicts NSCLC prognosis and its associated small nucleolar RNAs drive proliferation and migration [ncRNA-seq]
GSE161232	NOP10 predicts NSCLC prognosis and its associated small nucleolar RNAs drive proliferation and migration
GSE161517	Regulation of FOXA1 protein stability by Polycomb and BUB3/USP7 deubiquitin complexes in prostate cancer [ChIP-Seq]
GSE161519	Regulation of FOXA1 protein stability by Polycomb and BUB3/USP7 deubiquitin complexes in prostate cancer
GSE164939	Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target
GSE169521	Torque Teno Mini Virus as a cause of childhood acute promyelocytic leukemia lacking PML/RARA fusion
GSE175697	PALI1 Promotes Tumor Growth through Competitive Recruitment of PRC2 to G9A-target Chromatin for Dual Epigenetic Silencing
GSE181559	IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression [human RNA-seq]
GSE181582	IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression
GSE184724	The dynamic rRNA ribomethylome drives stemness in acute myeloid leukemia [ribomethseq_FBL_KD]
GSE184728	The dynamic rRNA ribomethylome drives stemness in acute myeloid leukemia
GSE185719	MiRNA Deregulation Distinguishes Anaplastic Thyroid Carcinoma (ATC) and Supports Upregulation of Oncogene Expression
GSE212133	Establishing mRNA and miRNA interactions driving disease heterogeneity in ALS patient survival (miRNA-Seq)
GSE212134	Establishing mRNA and microRNA interactions driving disease heterogeneity in Amyotrophic lateral sclerosis
GSE212625	PALI1 Promotes Tumor Growth through Competitive Recruitment of PRC2 to G9A-target Chromatin for Dual Epigenetic Silencing [ChIP-seq]
GSE213203	5hmC modification of monocytes and macrophages
GSE213207	5hmC and m6a modification and Translatomes of monocytes and macrophages
GSE242913	LITAF PROMOTES MEMBRANE REPAIR AGAINST PORE-FORMING PROTEINS
GSE247723	ISGF3 and STAT2/IRF9 direct basal and IFN-induced transcription through genome-wide binding of phosphorylated and unphosphorylated complexes to commonly ISRE containing ISGs  [RNA-Seq]
GSE247724	ISGF3 and STAT2/IRF9 direct basal and IFN-induced transcription through genome-wide binding of phosphorylated and unphosphorylated complexes to commonly ISRE containing ISGs  [ChIP-Seq]
GSE247728	ISGF3 and STAT2/IRF9 direct basal and IFN-induced transcription through genome-wide binding of phosphorylated and unphosphorylated complexes to commonly ISRE containing ISGs